CDEK
← All organizations

Medarex

For profitContributed to NME

Also known as: Medarex

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 21, 2003

First marketed drug

Aug 19, 1997

Last known activity

Aug 1, 2010

Acquired by Bristol-Myers Squibb on Jan 1, 2009

Timeline

1980s

  1. Jan 1, 1987

    Medarex— Founded

1990s

  1. Dec 10, 1996

    Houston Biotechnology— Acquired

  2. Jan 1, 1997

    Genpharm— Acquired

2000s

  1. Jan 1, 2004

    Ability Biomedical— Acquired

  2. Jul 9, 2007

    amlodipine— Marketing Organization

  3. Jan 1, 2009

    Bristol-Myers Squibb— Acquired By

Drugs by trial phase (28 distinct, 24 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (18)

Details

Founded
Princeton, NJ, US Jan 1, 1987
Last known activity
Aug 1, 2010